<atl>Interleukin‐18 levels are associated with disease course in patients with Still's disease treated with scpIL/scp ‐1 inhibitors</atl>

Journal:
Arthritis & Rheumatology
Published:
DOI:
10.1002/art.70024
Affiliations:
2
Authors:
9
Go to article
Institutions Authors Share
IRCCS Bambino Gesù Children's Hospital, Italy
9.000000
 1.00
Interested in Cardiovascular Medicine and Haematology?